4//SEC Filing
DEVINE THOMAS P 4
Accession 0001217747-11-000004
CIK 0001026650other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:49 PM ET
Size
22.3 KB
Accession
0001217747-11-000004
Insider Transaction Report
Form 4
DEVINE THOMAS P
Exec V.P. & Chief Dev Officer
Transactions
- Award
Option (Right to Buy)
2011-03-02$6.46/sh+31,553$203,832→ 31,553 totalExercise: $6.46Exp: 2018-03-02→ Common Stock, $.01 par value (31,553 underlying) - Tax Payment
Common Stock, $.01 par value
2011-03-02$6.32/sh−1,284$8,115→ 22,352 total - Award
Common Stock, $.01 par value
2011-03-02+15,093→ 37,445 total
Holdings
- 28,547
Option (Right to Buy)
Exercise: $6.05Exp: 2017-02-26→ Common Stock, $.01 par value (28,547 underlying) - 25,000
Option (Right to Buy)
Exercise: $12.00Exp: 2018-02-28→ Common Stock, $.01 par value (25,000 underlying) - 50,000
Option (Right to Buy)
Exercise: $4.60Exp: 2016-03-02→ Common Stock, $.01 par value (50,000 underlying) - 7,500
Option (Right to Buy)
Exercise: $12.00From: 2009-02-28Exp: 2015-02-28→ Common Stock, $.01 par value (7,500 underlying) - 20,000
Option (Right to Buy)
Exercise: $7.41Exp: 2014-02-23→ Common Stock, $.01 par value (20,000 underlying) - 20,000
Option (Right to Buy)
Exercise: $14.70Exp: 2013-02-10→ Common Stock, $.01 par value (20,000 underlying) - 20,000
Option (Right to Buy)
Exercise: $15.46Exp: 2012-02-14→ Common Stock, $.01 par value (20,000 underlying) - 43,688
Option (Right to Buy)
Exercise: $6.29Exp: 2013-04-22→ Common Stock, $.01 par value (43,688 underlying) - 17,375
Option (Right to Buy)
Exercise: $4.21Exp: 2012-10-22→ Common Stock, $.01 par value (17,375 underlying) - 27,000
Option (Right to Buy)
Exercise: $22.09Exp: 2014-02-09→ Common Stock, $.01 par value (27,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock grant that vests in four equal annual installments beginning one year after date of grant.
- [F2]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
- [F3]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable six years prior to expiration.
- [F4]25% of the total options granted became exercisable one year after date of grant. The remaining 75% became exercisable in December 2005.
Documents
Issuer
ERESEARCHTECHNOLOGY INC /DE/
CIK 0001026650
Entity typeother
Related Parties
1- filerCIK 0001228273
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:49 PM ET
- Size
- 22.3 KB